S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMAMaria Cristina Pirosa, Davide Rossi, Lodovico Terzi di Bergamo et al.|HemaSphere|2022Cited by 1